In the Gut GLP-1 receptors in the gut play a role in slowing gastric emptying, which prolongs the feeling of fullness after meals
Since this is a new delivery platform of existing drugs rather than a new drug, the regulatory bodies in many jurisdictions typically have alternative, shorter approval pathways available to drug sponsors that do not require the standard Phase I-III clinical trials for a new drug application
You should consult your doctor before starting a supplementation program that includes any form of vitamin C if you have hemochromatosis, any type of hemolytic anemia, G6PD deficiency, known kidney insufficiency or failure, or you are currently taking a blood thinner like warfarin (Coumadin)
This constant exposure means diabetic patients here need more aggressive eye protection and more frequent monitoring than national guidelines suggest
It is important to note that GLP-1 receptor agonists are not FDA-approved specifically for the treatment of MASLD or MASH, though they may be used off-label in appropriate patients